詢價車

化學材料

(+)-1,13-Bis(diphenyl)phosphino-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (R,R,R)-(+)-Ph-SKP

(+)-1,13-Bis(diphenyl)phosphino-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (R,R,R)-(+)-Ph-SKP

15-4310 / 100mg
加入洽詢
(+)-1,13-Bis(diphenyl)phosphino-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (R,R,R)-(+)-Ph-SKP

(+)-1,13-Bis(diphenyl)phosphino-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (R,R,R)-(+)-Ph-SKP

15-4310 / 25mg
加入洽詢
(-)-1,13-Bis(diphenyl)phosphino-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (S,S,S)-(-)-Ph-SKP

(-)-1,13-Bis(diphenyl)phosphino-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (S,S,S)-(-)-Ph-SKP

15-4311 / 100mg
加入洽詢
(-)-1,13-Bis(diphenyl)phosphino-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (S,S,S)-(-)-Ph-SKP

(-)-1,13-Bis(diphenyl)phosphino-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (S,S,S)-(-)-Ph-SKP

15-4311 / 25mg
加入洽詢
(+)-1,13-Bis[di(3,5-dimethylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (R,R,R)-(+)-Xyl-SKP

(+)-1,13-Bis[di(3,5-dimethylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (R,R,R)-(+)-Xyl-SKP

15-4320 / 100mg
加入洽詢
(+)-1,13-Bis[di(3,5-dimethylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (R,R,R)-(+)-Xyl-SKP

(+)-1,13-Bis[di(3,5-dimethylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (R,R,R)-(+)-Xyl-SKP

15-4320 / 25mg
加入洽詢
(+)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (R,R,R)-(+)-Tol-SKP

(+)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (R,R,R)-(+)-Tol-SKP

15-4330 / 100mg
加入洽詢
(+)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (R,R,R)-(+)-Tol-SKP

(+)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (R,R,R)-(+)-Tol-SKP

15-4330 / 25mg
加入洽詢
(-)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (S,S,S)-(-)-Tol-SKP

(-)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (S,S,S)-(-)-Tol-SKP

15-4331 / 100mg
加入洽詢
(-)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (S,S,S)-(-)-Tol-SKP

(-)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (S,S,S)-(-)-Tol-SKP

15-4331 / 25mg
加入洽詢
Phenylphosphine, 99%

Phenylphosphine, 99%

15-4400 / 10g
加入洽詢
Phenylphosphine, 99%

Phenylphosphine, 99%

15-4400 / 2g
加入洽詢
Phenylphosphine, 99% (Sure/Seal™ bottle)

Phenylphosphine, 99% (Sure/Seal™ bottle)

15-4402 / 25g
加入洽詢
Phenylphosphine, 99% (10 wt% in hexanes)

Phenylphosphine, 99% (10 wt% in hexanes)

15-4403 / 100g
加入洽詢
Phenylphosphine, 99% (10 wt% in hexanes)

Phenylphosphine, 99% (10 wt% in hexanes)

15-4403 / 20g
加入洽詢
Phosphaadamantane ethyl Silica (free phosphine ligand) (PhosphonicS PAr)

Phosphaadamantane ethyl Silica (free phosphine ligand) (PhosphonicS PAr)

15-4510 / 2g
加入洽詢
Phosphaadamantane ethyl Silica (free phosphine ligand) (PhosphonicS PAr)

Phosphaadamantane ethyl Silica (free phosphine ligand) (PhosphonicS PAr)

15-4510 / 500mg
加入洽詢
Phosphonitrilic chloride trimer, 98.5%

Phosphonitrilic chloride trimer, 98.5%

15-4530 / 10g
加入洽詢
Phosphonitrilic chloride trimer, 98.5%

Phosphonitrilic chloride trimer, 98.5%

15-4530 / 50g
加入洽詢
N-[2-(Diphenylphosphinyl)ethyl]-2-(methylthio)-ethanamine

N-[2-(Diphenylphosphinyl)ethyl]-2-(methylthio)-ethanamine

15-4620 / 250mg
加入洽詢
N-[2-(Diphenylphosphino)ethyl]-2-(methylthio)-ethanamine

N-[2-(Diphenylphosphino)ethyl]-2-(methylthio)-ethanamine

15-4625 / 50mg
加入洽詢
N-[2-(Diphenylphosphinyl)ethyl]-2-(phenylthio)-ethanamine

N-[2-(Diphenylphosphinyl)ethyl]-2-(phenylthio)-ethanamine

15-4630 / 100mg
加入洽詢
N-[2-(Diphenylphosphino)ethyl]-2-(phenylthio)-ethanamine

N-[2-(Diphenylphosphino)ethyl]-2-(phenylthio)-ethanamine

15-4635 / 50mg
加入洽詢
N-[2-(Diphenylphosphinyl)ethyl]-2-[(4-methylphenyl)thio]-ethanamine

N-[2-(Diphenylphosphinyl)ethyl]-2-[(4-methylphenyl)thio]-ethanamine

15-4640 / 250mg
加入洽詢
N-[2-(Diphenylphosphino)ethyl]-2-[(4-methylphenyl)thio]-ethanamine

N-[2-(Diphenylphosphino)ethyl]-2-[(4-methylphenyl)thio]-ethanamine

15-4645 / 100mg
加入洽詢
N-[2-(Diphenylphosphinyl)ethyl]-2-[tritylthio]-ethanamine

N-[2-(Diphenylphosphinyl)ethyl]-2-[tritylthio]-ethanamine

15-4660 / 250mg
加入洽詢
2-[(1,1-Dimethylethyl)thio]-N-[2-(diphenylphosphino)ethyl]-ethanamine

2-[(1,1-Dimethylethyl)thio]-N-[2-(diphenylphosphino)ethyl]-ethanamine

15-4665 / 50mg
加入洽詢
2-[(1,1-Dimethylethyl)thio]-N-[2-(diphenylphosphinyl)ethyl]-ethanamine

2-[(1,1-Dimethylethyl)thio]-N-[2-(diphenylphosphinyl)ethyl]-ethanamine

15-4670 / 250mg
加入洽詢
(11aR)-(+)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (R)-FuP-tBu

(11aR)-(+)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (R)-FuP-tBu

15-5130 / 100mg
加入洽詢
(11aR)-(+)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (R)-FuP-tBu

(11aR)-(+)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (R)-FuP-tBu

15-5130 / 25mg
加入洽詢
(11aS)-(-)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (S)-FuP-tBu

(11aS)-(-)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (S)-FuP-tBu

15-5131 / 100mg
加入洽詢
(11aS)-(-)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (S)-FuP-tBu

(11aS)-(-)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (S)-FuP-tBu

15-5131 / 25mg
加入洽詢
n-Tetradecylphosphonic acid, min. 97% TDPA

n-Tetradecylphosphonic acid, min. 97% TDPA

15-5145 / 1g
加入洽詢
n-Tetradecylphosphonic acid, min. 97% TDPA

n-Tetradecylphosphonic acid, min. 97% TDPA

15-5145 / 25g
加入洽詢
n-Tetradecylphosphonic acid, min. 97% TDPA

n-Tetradecylphosphonic acid, min. 97% TDPA

15-5145 / 5g
加入洽詢
(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(6-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP-6-Me

(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(6-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP-6-Me

15-5148 / 100mg
加入洽詢
(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(6-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP-6-Me

(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(6-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP-6-Me

15-5148 / 25mg
加入洽詢
(11aR)-(+)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (R)-SIPHOS

(11aR)-(+)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (R)-SIPHOS

15-5150 / 100mg
加入洽詢
(11aR)-(+)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (R)-SIPHOS

(11aR)-(+)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (R)-SIPHOS

15-5150 / 500mg
加入洽詢
(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (S)-SIPHOS

(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (S)-SIPHOS

15-5151 / 100mg
加入洽詢
(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (S)-SIPHOS

(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (S)-SIPHOS

15-5151 / 500mg
加入洽詢
(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-phenoxy, min. 98% (S)-ShiP

(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-phenoxy, min. 98% (S)-ShiP

15-5157 / 100mg
加入洽詢
(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-phenoxy, min. 98% (S)-ShiP

(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-phenoxy, min. 98% (S)-ShiP

15-5157 / 500mg
加入洽詢
(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(3-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP-3-Me

(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(3-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP-3-Me

15-5158 / 100mg
加入洽詢
(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(3-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP-3-Me

(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(3-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP-3-Me

15-5158 / 25mg
加入洽詢
(S)-(-)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(3-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (S)-DTB-SpiroPAP-3-Me

(S)-(-)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(3-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (S)-DTB-SpiroPAP-3-Me

15-5159 / 100mg
加入洽詢
(S)-(-)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(3-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (S)-DTB-SpiroPAP-3-Me

(S)-(-)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(3-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (S)-DTB-SpiroPAP-3-Me

15-5159 / 25mg
加入洽詢
(11aR)-(+)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine, min. 98% (R)-SIPHOS-PE

(11aR)-(+)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine, min. 98% (R)-SIPHOS-PE

15-5162 / 100mg
加入洽詢
(11aR)-(+)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine, min. 98% (R)-SIPHOS-PE

(11aR)-(+)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine, min. 98% (R)-SIPHOS-PE

15-5162 / 500mg
加入洽詢
(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine, min. 98% (S)-SIPHOS-PE

(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine, min. 98% (S)-SIPHOS-PE

15-5163 / 100mg
加入洽詢
LOCATIONS

服務據點

北北基/宜蘭/花蓮
  • 北北基/宜蘭/花蓮
  • 桃園
  • 新竹縣/新竹市/苗栗
  • 台中/彰化/南投
  • 雲林/嘉義/台南
  • 高雄/屏東/台東

台北分公司

地址 台北市南港區南港路三段50巷10號5樓
電話 02-2786-2331
傳真 02-2653-6959
郵件 taipei@echochemical.com

桃園分公司

地址 桃園市平鎮區復興街62號2樓
電話 03-494-6939
傳真 03-493-0687
郵件 chungli@echochemical.com

總公司 / 竹苗分公司

地址 苗栗縣頭份市工業路16號
電話 037-621-088
傳真 037-615-096
郵件 miaoli@echochemical.com

台中分公司

地址 台中市南屯區文心路一段218號15F之2
電話 04-2472-8859
傳真 04-2472-8825
郵件 taichung@echochemical.com

台南分公司

地址 台南市永康區鹽洲一街63巷33號
電話 06-243-6589
傳真 06-253-8208
郵件 tainan@echochemical.com

高雄分公司

地址 高雄市鳳山區鳳頂路479號
電話 07-753-9988
傳真 07-753-1958
郵件 kaohsiung@echochemical.com
北北基/宜蘭/花蓮 桃園 新竹縣/新竹市/苗栗 台中/彰化/南投 雲林/嘉義/台南 高雄/屏東/台東
mapNorth
mapTaoyuan
mapHsinchu
mapCentral
mapYunlin
mapSouth
詢價車
洽詢車

你的洽詢車總計 0 件產品

洽詢表單
依據歐盟施行的個人資料保護法，我們致力於保護您的個人資料並提供您對個人資料的掌握。
按一下「全部接受」，代表您允許我們置放 Cookie 來提升您在本網站上的使用體驗、協助我們分析網站效能和使用狀況，以及讓我們投放相關聯的行銷內容。您可以在下方管理 Cookie 設定。 按一下「確認」即代表您同意採用目前的設定。
管理Cookies

隱私權偏好設定中心

依據歐盟施行的個人資料保護法，我們致力於保護您的個人資料並提供您對個人資料的掌握。
按一下「全部接受」，代表您允許我們置放 Cookie 來提升您在本網站上的使用體驗、協助我們分析網站效能和使用狀況，以及讓我們投放相關聯的行銷內容。您可以在下方管理 Cookie 設定。 按一下「確認」即代表您同意採用目前的設定。
查看隱私權政策

管理同意設定

必要的Cookie

一律啟用
網站運行離不開這些 Cookie 且您不能在系統中將其關閉。通常僅根據您所做出的操作（即服務請求）來設置這些 Cookie，如設置隱私偏好、登錄或填充表格。您可以將您的瀏覽器設置為阻止或向您提示這些 Cookie，但可能會導致某些網站功能無法工作。